Myelodysplastic Disorders
5 clinical trials · Condition
◉ Watch Myelodysplastic Disorders
| Record | Firm | Date |
|---|---|---|
| Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021) (NCT07445984) | Azienda Ospedaliero-Universitaria di Parma | 2021-07-28 |
| Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006) (NCT00542971) | M.D. Anderson Cancer Center | 2007-10-01 |
| Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H (NCT00048412) | Baylor College of Medicine | 2000-06-01 |
Track Myelodysplastic Disorders automatically
Every clearance here is in the API, with alerts when new ones post.